FIRST AMENDMENT TO COLLABORATION AGREEMENTCollaboration Agreement • April 4th, 2013 • Receptos, Inc. • Pharmaceutical preparations
Contract Type FiledApril 4th, 2013 Company IndustryThis AMENDMENT (the “Amendment”), dated as of March 14, 2011, to that certain Collaboration Agreement dated December 20, 2010 by and between Receptos, Inc., a Delaware corporation (“Receptos”) having its principal place of business at 10835 Road to the Cure, 2nd Floor, San Diego, CA 92121, and Eli Lilly and Company, an Indiana corporation (“Lilly”) having its principal place of business at Lilly Corporate Center, Indianapolis, Indiana 46285 USA, (the “Agreement”) is entered into by Receptos and Lilly (collectively, the “Parties”). The Parties agree to amend the Agreement as set forth herein:
FIRST AMENDMENT TO COLLABORATION AGREEMENTCollaboration Agreement • February 13th, 2013 • Receptos, Inc. • Pharmaceutical preparations
Contract Type FiledFebruary 13th, 2013 Company IndustryThis AMENDMENT (the “Amendment”), dated as of March 14, 2011, to that certain Collaboration Agreement dated December 20, 2010 by and between Receptos, Inc., a Delaware corporation (“Receptos”) having its principal place of business at 10835 Road to the Cure, 2nd Floor, San Diego, CA 92121, and Eli Lilly and Company, an Indiana corporation (“Lilly”) having its principal place of business at Lilly Corporate Center, Indianapolis, Indiana 46285 USA, (the “Agreement”) is entered into by Receptos and Lilly (collectively, the “Parties”). The Parties agree to amend the Agreement as set forth herein: